Charles A Culver is a pharmacist who is specialized in Pharmacotherapy in Marion, Illinois. Patients can reach him at 2401 W Main St, Marion or contact him on 618-998-5855. Charles A Culver is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Charles A Culver speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Charles A Culver
Specialization:
Pharmacotherapy
Credentials:
PHARM.D.
Gender:
Male
Location:
2401 W Main St, Marion, Illinois, 62959-1188
Phone:
618-998-5855
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Charles A Culver are as mentioned below.
NPI Number:
1518077866
NPI Enumeration Date:
30 Aug, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Charles A Culver are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
106 Philip Rd, Christopher, Illinois
Zip:
62822-2206
Phone Number:
--
Fax Number:
--
Patients can reach Charles A Culver at 2401 W Main St, Marion, Illinois or can call on phone at 618-998-5855.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.